ISSCA Announces Specialized Training Workshop in Pain Management and Cosmetic Gynecology
The International Society for Stem Cell Application (ISSCA) will host a specialized training conference in pain management and cosmetic gynecology in Madrid, Feb. 24-25, 2018. Featured speakers include three prominent experts in these specialized fields.
MIAMI, Nov. 13, 2017— The International Society for Stem Cell Application (ISSCA), a global leader in regenerative medicine education, research, and certification, will host a specialized training workshop in pain management and cosmetic gynecology for physicians and qualified health care practitioners at the Advanced Pain Management Center in Madrid, Feb. 24-25, 2018. The event will feature three distinguished speakers with diverse experience in these specialized fields.
Training at the event will focus on regenerative medicine solutions for pain management and cosmetic gynecology. Learning new techniques in pain management requires a thorough understanding of how to perform and administer the latest therapies that are simple for physicians to learn and execute in-office, but many haven’t learned them yet.
The field of cosmetic gynecology is associated with three specialties: gynecology, cosmetic surgery, and dermatology. It comprises a wide range of procedures, from vaginal rejuvenation to vaginoplasty and labiaplasty, and can involve surgery or non-invasive procedures that can be performed in-office without a need for anesthesia.
Speakers for the ISSCA Specialized Training Workshop in Pain Management and Cosmetic Gynecology, all experts in their fields, include:
Maritza Novas earned a medical degree at the University of Havana, Cuba in 1993. Novas, Director of Research and Development for Global Stem Cells Group, has been in the forefront of medical aesthetic and anti-aging medicine since 2001.
She has been a member of the American Academy of Anti-Aging Medicine since 2004 and draws upon 10 years of combined experience with facial aesthetics, hormonal replacement and nutritional therapies, liposculpture, and fat transfers. Novas is currently completing a master’s degree in Molecular Biology at Lehigh University.
A pioneer in the use of stem cells for aesthetic procedures and treatment of chronic degenerative conditions, she has trained more than 150 physicians in the U.S. and internationally on procedures and protocols for harvesting and isolating adipose-derived stem cells for autologous re-implantation, and with problem-solving methods to improve patient outcomes.
Novas specializes in stem cell procedures for cosmetic and anti-aging applications, tissue regeneration, functional medicine, age management, bio-identical hormone therapy, and weight control. Novas has been a certified Adistem specialist for more than four years.
As a member of Stem Cell Training, Inc.’s research and development team, Novas has assisted in the development of new proprietary adipose and bone marrow protocols currently being used in the company’s comprehensive stem cell training courses.
Ernesto Delgado Cidranes M.D., Ph.D., an expert in pain treatment and management, is a neuroanesthesiologist, and resuscitation and intensive care specialist in, Madrid, Spain. Cildranes provides an integrative and interdisciplinary approach to the treatment of pain and is a frequent speaker on the subject. His areas of expertise include interventional pain management, pain treatment, stem cell therapies, and regenerative medicine.
Cidranes is director, CEO, and founder at Advanced Pain and Aesthetic Management Center in Madrid. He serves as an editorial board member of the Journal Pain Management and Therapy; an editorial board member for the American Institute of Ultrasound in Medicine (AIUM); a reviewer and advisor for the Journal of Ultrasound in Medicine, American Institute, U.S.; a member of the World Pain Medicine Conferences organizing committee; chairman of the Department of Anesthesia and Pain Medicine, Spanish University Health Ministry. an international professor of advanced ultrasound in the Pain Unit at La Milagrosa and Los Madroños Hospitals in Madrid, and a staff member at Anesthesiology of Ruber Quirón Hospital in Madrid. He also serves on the Global Stem Cells Group Advisory Board.
Cidranes’ lecture for the event is titled “Stem Cells: Relieving pain, restoring function and generating hope.”
“The conscious, explicit, and judicious use of the best scientific evidence available to make
patient decisions is the key,” he says. “It is obvious that regenerative therapies have to carry the weight of medicine is based on scientific data I intend to show our experience on the use of stem cells in pain treatment to relieve pain, restore function and generate hope in our patients.”
According to Cidranes, research on the infusion of mesenchymal stem cells has clinical and technological monitoring in real time to guarantee the quality and safety of its extraction until its application. The treatment of pain is a human right and the application of stem cells is a tool, it´s a valid safety and demonstrates the option to improve the quality of life.
Zuramis ESTRADA BLANCO, M.D., is a cosmetic gynecologist and CEO, founder, and director of Advanced Aesthetic Surgery Center CIMEG Advanced Pain Management Center in Madrid.
Estrada specializes in obstetrics and aesthetic gynecology, senology and breast diseases, and pelvic floor disorders. She is a founding member of la Sociedad Española de Ginecoestética y Cirugía Intima (SEGECI), Spain’s first cosmetic gynecology society.
Zuramis teaches basic and advanced ultrasound in SERMAS to fourth- and fifth-year medical students at the Francisco de Vitoria University in Madrid, and serves as assistant specialist at Southeast University Hospital, also in Madrid.
She has dedicated more than 15 years to research and to the treatment of gynecological dysfunctions of women. She is president of the International Society of Aesthetic Gynecology and Research(ISGAR); a member of the expert committee of the International Association of Aesthetic Gynecology and Sexual Wellbeing (IAAGSW); general secretary of the Spanish Society of Gynecology Aesthetic Regenerative Functional (SEGERF); Creator of several working protocols for the treatment of pelvic floor and sexual dysfunctions, and a national and international guest speaker for courses and congresses in her field of medicine.
Click here to view a video of Zuramis’s recent lecture titled, “Vulvovaginal: pudendal pain relief with PRP and stem cells.”
To learn more about the ISSCA Specialized Training Workshop in Pain Management and Cosmetic Gynecology, visit http://stemcellsacademy.com, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
###
pain management workshop
- Published in Press Releases
Global Stem Cells Group to Represent CELLINK 3D Bioprinting Technology in Latin America
Global Stem Cells Group announces that it will represent CELLINK Bioprinting Technology in Latin America. CELLINK is the world’s first company to market bioinks for 3D bioprinting of human organs and tissue.
MIAMI, Nov. 9, 2017—Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announces it will represent CELLLINK 3D Bioprinting Technology in Latin America. CELLINK is the world’s first company biotech company to market bioinks for 3D bioprinting of human organs and tissue.
GSCG will also market CELLINK’S newest product, BIO X printer for researchers, life science companies, and innovators who work with bioprinting on its subsidiary Adimarket.net website.
3D bioprinting of human tissues and organs is a revolutionary technology in the field of tissue engineering. One of the major challenges in stem cell research and tissue engineering is mimicking the micro and macro environment of human tissues. A favorable functional outcome is extremely dependent on the level to which tissue scientist and engineers are able to control the inner micro- and macro-scale features of engineered-tissue. In response to this challenge, advances in additive manufacturing inspired scientists to develop and adapt 3D bioprinting technology for human tissues and organs.
“Our objective is to bring this cutting-edge 3D bioprinting technology to scientists and regenerative medicine researcher throughout Lain America,” says Global Stem Cells Group founder and CEO Benito Novas. “CELLINK has revolutionized tissue engineering with its range of bioprinters, and we’re excited to make this process available to scientists and regenerative medicine researchers in Mexico, Central America, and South America.
“This opportunity is ideally suited to Global Stem Cells’ commitment to advancing the benefits of stem cell medicine in Latin America and worldwide, Novas says.”
To learn more about Global Stem Cells Group, visit the GSCG website, email info@stemcellsgroup.com, or call +1305 560 5337.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
About AdiMarket:
Adimarket, Inc., a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals.
Adimarket was founded to provide practitioners the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting-edge treatments.
###
CELLLINK 3D bioprinting technology
- Published in Press Releases
Global Stem Cells Group Names Aesthetic Polyclinic Exclusive Representative in Abu Dhabi
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
MIAMI, Nov. 9, 2017—Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, has added Aesthetic Polyclinic to its worldwide regenerative medicine network, naming it the exclusive representative for GSCG in Abu Dhabi.
This new alliance is part of Global Stem Cells Group’s worldwide expansion of its clinical presence, partnering with qualified physicians experienced in stem cell therapies to open new clinics and utilize GSCG stem cell products and protocols in patient treatments. To date, GSCG has established similar alliances in 32 cities worldwide.
Aesthetic Polyclinic will provide advanced stem cell protocols and state-of-the-art techniques in stem cell therapies to patients from around the world. Aesthetic Polyclinic is GSCG’ fourth clinical presence in the Middle East, including Morocco, Iraq, and Pakistan.
Aesthetic Polyclinic specializes in plastic surgery, aesthetic medicine, dermatology, and general and cosmetic dentistry. The alliance with GSCG will add the benefits of stem cell applications for aesthetic and anti-aging treatments to the organization’s catalog of patient services. According to Sela Al Asadi, Managing Director for Aesthetic Polyclinic, the alliance is ideally suited to both organizations’ mission.
“Like Global Stem Cells Group, we are committed to meeting the growing needs of our clients and patients, and we continuously search for and adopt the latest medical technology and services,” Al Asadi says. “Our staff of committed, efficient, and customer-centric professionals is excited to represent Global Stem Cells Group and offer the benefits of their regenerative medicine products and protocols to our patients.”
Global Stem Cells Group provides stem cell treatments for a variety of conditions, diseases, and aesthetic treatments at facilities worldwide. The new facility will have an international staff that is experienced in administering the leading cellular therapies available.
Global Stem Cells Group’s Abu Dhabi clinic is certified for the medical tourism market, and staff physicians are board-certified or board-eligible. GSCG clinics provide services in more than 10 specialties, attracting patients from the United States and around the world.
Global Stem Cells Group is committed to providing the highest standards of services and technology, expert and compassionate care, and a philosophy of exceeding the expectations of their international patients.
To learn more about Global Stem Cells Group, visit the GSCG website, email info@stemcellsgroup.com, or call +1305 560 533
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global Stem Cell Group’s aim is to be the largest recognized stem cell and regenerative medicine network in the world.
About Aesthetic Polyclinic
Aesthetic Polyclinic has been serving the residents of Abu Dhabi and Al Ain since 2000, providing world-class aesthetic services including plastic surgery dermatology, IPL hair removal, cosmetic and general dentistry, weight loss and body treatments, and specialized skin care.
One of Abu Dhabi’s top healthcare clinics, Aesthetic Polyclinic values the distinctly individual nature of all its clients and patients and prides itself in delivering quality customer service through customer focus, innovation, cutting-edge technology, and a commitment to excellence.
Formerly Aesthetic Skincare, it became Aesthetic Polyclinic in 2009 upon introducing dermatology and plastic surgery services. In 2013, the organization expanded its medical services with a brand new, state-of-the-art dedicated medical building and introducing dental and orthodontic services.
###
Aesthetic Polyclinic
- Published in Press Releases
Adimarket, a division of Global Stem Cells Group, Launches New Website, Expanded Product and Purchasing Options
AdiMarket has launched a new website offering regenerative medicine customers new product and purchasing options on an e-commerce mega-store scale.
MIAMI, Nov. 9, 2017—Adimarket, a leading provider of in-office regenerative medicine products and solutions, has changed its corporate mission and launched a new website to reflect its new direction toward online mega-store status. The aim is to become the eBay or Amazon of regenerative medicine products.
Adimarket, a subsidiary of Global Stem Cells Group, has a new mission that borrows from marketplace strategies used by e-commerce giants Amazon and eBay, which means more products and more buying options for regenerative medicine practitioners.
eBay and Amazon are arguably the two biggest e-commerce sites out there, but they function very differently. AdiMarket’s new website utilizes e-commerce strategies of both. eBay’s model takes no inventory and acts as an intermediary that facilitates peer-to-peer (P2P) commerce. Amazon, in addition to warehousing inventory, utilizes an end-to-end production to consumer (P2C) model that allows buyers to purchase from independent companies directly from the Amazon website, and products are shipped directly from producers to consumers, with no intermediary necessary for greater convenience.
Despite their contrary e-commerce strategies, Amazon and eBay are each other’s fiercest competitors. Both companies’ approaches have pros and cons—it’s the pros of the two strategies that AdiMarket is leveraging to achieve its new corporate mission. The company will stock and promote regenerative medicine products for specific brands and manufacturers, and at the same time promote products from all providers of regenerative medicine products, systems, kits, and equipment using P2C commerce platform as well as a peer-to-peer (P2P) platform.
“We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group. “We aim to be the go-to, one-stop-shop for all regenerative medicine that physicians and practitioners want or need.”
In addition, AdiMarket now has the capabilities to build and install high-performing in-office laboratories for physicians and practitioners requiring more complex lab equipment for stem cell culturing, expansion, and cryopreservation.
To learn more about Adimarket’s new mission and expanded e-commerce marketplace, visit https://www.adimarket.netemail, email info@stemcellsgroup.com, or call +1305 560 5337.
About AdiMarket:
Adimarket, Inc., a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals.
Adimarket was founded to provide practitioners the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting-edge treatments.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
###
Adimarket launches website
- Published in Press Releases
ISSCA and Global Stem Cells Group to Sponsor the XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery and Obesity Nov. 30 – Dec. 3, 2017, in Mexico City
The International Society for Stem Cell Application (ISSCA), and Global Stem Cells Group (GSCG) will sponsor the XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery Obesity. ISSCA and GSCG will launch their new online regenerative medicine training course, and will also launch a new adipose stem cell isolation kit, STEMPIA, at the event.
.
MIAMI, Nov. 9, 2017— The International Society for Stem Cell Application (ISSCA), a global leader in promoting education and setting standards in regenerative medicine, in collaboration with and Global Stem Cells Group (GSCG) will sponsor the XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery and Obesity Nov. 30 – Dec. 3, 2017, in Mexico City.
Hosted by the Institute of Higher Studies in Medicine (IESM), the annual International Congress is among the largest and most well-attended aesthetic medicine events in Ibero-America. More than 1,000 physicians from around the world are expected to attend. This year’s speaker lineup includes a renowned group of professionals in the field of regenerative medicine.
ISSCA and GSCG plan to leverage the large gathering of regenerative medicine and healthcare professionals at the International Congress to launch the newest cutting-edge online regenerative medicine training course in collaboration with Stem Cell Training, Inc.
The new virtual regenerative medicine training course is designed to instruct qualified physicians in the theoretical and practical protocols necessary to effectively and expertly administer regenerative medicine procedures to their patients. Training includes instructions for harvesting and isolating stem cells. The online training program positions physicians to provide stem cell procedures in their existing practice or open a stem cell center practice and join ISSCA’s international network of stem cell specialists.
In addition, the organizations will launch STEMPIA, a new adipose-derived stem call kit. The kit provides two specially designed tubes to isolate and concentrate adipose tissue-derived stromal vascular fraction (SVF). STEMPIA offers an easier, more effective, and shorter process for SVF isolation while maintaining high viability rates. STEMPIA uses less consumables and tools compared to manual SVF isolation processes, saving both costs and time in the SVF isolation process.
ISSCA, and GSCG will also be conducting a two-day, intensive regenerative medicine certification course for qualified physicians in Mexico City following the congress. Attendees will gain hand-on training and learn how to harvest and isolate stem cells, and expertly administer stem cell treatments to patients.. Upon completing the course, participants will receive certification and will be able to use their skills to treat patients in their practice, and for career advancement.
Fiesta Americana Reforma is the conference venue and headquarters. Visit the hotel data website page for location and additional information.
To learn more about the International Conference, visit the conference website email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s aim is to be the largest recognized stem cell and regenerative medicine network in the world.
###
XVIII International Congress of Aesthetic Medicine, Aesthetic Surgery Obesity
- Published in Press Releases
ISSCA Confirms Date for its First 2018 Fellowship in Cell Therapy and Tissue Engineering
The International Society for Stem Cell Application (ISSCA) has scheduled the first Cell Therapy and Tissue Engineering Fellowship in the upcoming year for March 5, 2018. The 6-day immersive program will be held in Seoul, Korea.
MIAMI, Nov. 9, 2017—The International Society for Stem Cell Application (ISSCA), a global leader in regenerative medicine education, research, and certification, will hold the first Cell Therapy and Tissue Engineering fellowship for the upcoming year on March 5, 2018, in Seoul, Korea.
Following up on the success of the organization’s series of fellowships in 2017, ISSCA decided to continue to offer the opportunity to graduate and post-doctoral students. Participants will engage with world-class stem cell and regenerative medicine experts in an immersive, hands-on experience focused on stem cell characterization and laboratory applications including cell culture, plating, trypsinization, harvesting, and cryopreservation. Fellowship attendants also gain an understanding of control tests including cell count, viability, flow cytometry, endotoxin, mycoplasma, and sterility.
“The very nature of stem cell therapy and tissue engineering necessitates practical, immersive, and skillfully monitored participation for students training in the application of stem cells,” says Benito Novas, ISSCA Public Relations Director and founder of Global Stem Cells Group. “The opportunity to actively engage while learning theoretical and analytical methods from mentors working to create new medical technologies and laboratory applications in one of the most rapidly growing areas of biomedical engineering is highly advantageous.
“Bio-medical scientists encounter many challenges before tissue engineering therapies reach clinical use and widespread application,” Novas says. “Cell therapy and tissue engineering offer vast potential for a career as a practitioner or researcher in which today’s students can be tomorrow’s pioneers in improving the efficacy of medical treatments and advancing the healthcare industry.”
And since so many tissues and organs are excellent candidates for engineering new treatments and cures for diseases, including blood vessel, bone, cartilage, liver, pancreas, peripheral nerve, and skin cells, the future of regenerative medicine has the potential to revolutionize disease remediation and tissue repair
The ISSCA Fellowship in Cell Therapy and Tissue Engineering is a 6-day workshop that offers a certificate of completion issued by ISSCA and Westminster International University in Seoul. Students who complete the fellowship become members of the ISSCA’s international network of regenerative medical professionals and standard setters, with access to events, resources, training, and support moving forward.
ISSCA is the only organization that provides a complete Cell Therapy and Engineering Tissue Fellowship focused on regenerative medicine. It is also the only fellowship of its kind supported by Korean Universities.
To learn more about the ISSCA fellowship and to reserve a spot at the March 8, 2018 program in Korea, visit http://stemcellsacademy.com, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
###
.
ISSCA 2018 Korea Fellowship
- Published in Press Releases
ISSCA to Conduct Regenerative Medicine Certification Training for Physicians in Buenos Aires, Argentina November 26 – 27, 2017
The International Association for Stem Cell Application (ISSCA) will be conducting a regenerative medicine certification course for physicians in Buenos Aires Nov. 26-27, 2017. The two-day intensive training course teaches trainees extraction, isolation, and application of PRP, adipose, and bone marrow stem cells.
MIAMI, Nov. 9, 2017— The International Society for Stem Cell Application (ISSCA), a global leader in regenerative medicine training, has announced plans to conduct regenerative medicine certification training for physicians in Buenos Aires, Argentina November 26 – 27, 2017.
The ISSCA training course, available to qualified physicians interested in adding regenerative medicine to their practice procedures, provides hands-on, practical instruction under the guidance of trained medical experts in a highly visual, interactive, and clinical learning environment.
.ISSCA’s medical professionals teach reintegration and procedural techniques on live patients using different protocols for isolating stem cells. Trainees will participate in different medical cases under the supervision of trained specialists.
This hands-on stem cell training course provides each participant with a live demonstration of the extraction, isolation, and application of PRP, adipose, and bone marrow stem cells. Techniques and materials used in the course, along with high-resolution, step-by-step procedure videos are provided for the participating physician’s future use and reference.
Led by ISSCA’s established team of skilled practitioners, this course is designed specifically to provide personalized instruction. Seats for each course are limited to 8-10 trainees, not only to suit each participant’s individual training needs but also to allow for professional networking.
Participants who complete the training will receive certification that documents their participation in and completion of the training, their and their knowledge and skills in the field of regenerative medicine. Certification candidates are required to provide proof of prior medical training and experience, and successfully complete a written as well as an oral/practical exam. Certification confirms a physician’s expertise in regenerative medicine.
Certification procedures and requirements are key to the integrity of regenerative medicine. They furnish a reputable credential that is essential not only for patients to see, but also to a physician’s practice.
The Buenos Aires certification training course will mark the 11th event ISSCA has sponsored and hosted thus far in 2017. The organization is working to position itself as a reference point for regenerative medical practitioners worldwide. With a presence in more than 25 countries, physicians interested in certification can check for an ISSCA training course near them by visiting the https://www.stemcelltraining.net/ website, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
. ###
Regenerative medicine certification training
- Published in Press Releases
AdiMarket, a division of Global Stem Cells Group, to sponsor American Academy of Anti-Aging Medicine (A4M) 25th Annual World Congress in Las Vegas Dec. 14 – 16, 2017
(Pictured at left) Integrated Stem Cell Work Station, a new multi-functional bio-work station from AdiMarket,
Adimarket, a division of Global Stem Cells Group announces its sponsorship of the 25th Annual American Academy of Anti-Aging Medicine (A4M) World Congress in Las Vegas Dec. 14-16. GSCG plans to launch two new products for stem cell and regenerative medicine practitioners at the event.
MIAMI, Nov. 9, 2017—Adimarket, a division of Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announces its sponsorship of the 25th Annual American Academy of Anti-Aging Medicine (A4M) World Congress in Las Vegas, Dec. 14 – 16, 2017. This year marks a quarter-century in A4M’s mission to build awareness and deliver innovative, cutting-edge scientific education in the field of anti-aging medicine.
A4M focuses on longevity and prolonging the lifespan of people worldwide. Global Stem Cells Group shares A4M’s commitment to promoting anti-aging medicine, having organized five regenerative medicine symposiums and other medical conferences highlighting anti-aging research and therapies in 2017.
Global Stem Cells Group will leverage the large gathering of regenerative medicine and healthcare professionals at theInternational Congress to launch its newest cutting-edge online regenerative medicine training course in collaboration with StemCell Training, Inc.
The new virtual regenerative medicine training course is designed to instruct qualified physicians in the theoretical and practical protocols necessary to effectively and expertly administer regenerative medicine procedures to their patients. Training includes instructions for harvesting and isolating stem cells. The online training program positions physicians to provide stem cell procedures in their existing practice or open a stem cell center practice and join ISSCA’s international network of stem cell specialists.
GSCG will also launch two new products at the A4M conference:
- STEMPIA, a new adipose-derived stem cell kit. The kit provides two specially designed tubes to isolate and concentrate adipose tissue-derived stromal vascular fraction (SVF). STEMPIA offers an easier, more effective, and shorter process for SVF isolation while maintaining high viability rates. STEMPIA uses fewer consumables and tools compared to manual SVF isolation processes, saving both costs and time in the SVF isolation process.
- The latest Integrated Stem Cell Work Station from AdiMarket, a multi-functional bio-work station that allows physicians to perform stem cell protocols and procedures within an enclosed controlled culture environment. The Integrated Stem Cell Work Station is equipped with a built-in centrifuge, shaking incubator, laminar flow hood and other features to ensure a clean environment for stem cell isolation and handling. It can also be customized to accommodate insertion of supplementary device(s) in work station.
The American Academy of Anti-Aging Medicine (A4M) 25th Annual World Congress will be hosted at the Venetian and Palazzo Resort, a hotel and casino resort located on the Las Vegas Strip.
To learn more about the A4M World Congress, visit the event website. For more information about Global Stem Cells Group, visit the GSCG website, email info@stemcellsgroup.com, or call +1305 560 5337.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s aim is to be the largest recognized stem cell and regenerative medicine network in the world.
About Adimarket:
Adimarket, Inc., a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and healthcare professionals.
Adimarket was founded to provide practitioners the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting-edge treatments.
###
A4M 25th Annual World Congress
- Published in Press Releases
ISSCA Announces its Regenerative Medicine Conferences Agenda for 2018
The International Association for Stem Cell Application (ISSCA) has announced plans to host three regenerative medicine symposiums in Istanbul, Turkey, Buenos Aires, Argentina, and Seoul, Korea in 2018. The Seoul symposium will be part of, the 6th Annual International Conference of ISSCA, “Progress and Perspectives,” which will be held in Seoul in November 2018.
MIAMI, Nov. 9, 2017—The International Association for Stem Cell Application (ISSCA) has announced plans to host three regenerative medicine symposiums in the upcoming year:
- Istanbul, Turkey, April 2018
- Buenos Aires, Argentina, August 2018
- Seoul, Korea, November 2018
The symposium series will culminate in the 6th Annual International Conference of ISSCA, Progress and Perspectives, in Seoul, Korea in November 2018.
The three international symposiums are part of ISSCA’s mission to support a paradigm shift in healthcare from traditional to regenerative medicine in the 21st Century and provide cutting-edge information on developments in all areas of stem cell research. Each event will host a group of renowned international speakers in the field of stem cell and regenerative medicine, who will offer a day of rigorous scientific discourse aimed at physicians.
Each ISSCA symposium will incorporate the biology, medicine, applications, regulations, product development, and commercialization of stem cells. Business opportunities, challenges, and potential strategies for overcoming these challenges will also be addressed.
The central theme of each international symposium is as follows:
• Istanbul: Advances in Cell Therapies
• Buenos Aires: Next Generation Medicine: Adult Stem Cells
• Seoul: This seminar will be part of the 6th Annual International Conference of ISSCA, “Progress and Perspectives”
Symposium dates and details will be available shortly. To learn more about the ISSCA symposiums and 6th Annual International Conference of ISSCA, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
.###
Regenerative medicine symposiums 2018 ISSCA
- Published in Press Releases
Global Stem Cells Group Announces New Turn-Key Solution for Stem Cell Processing
Global Stem Cells Group and its affiliate AdiMarket announce the new Turn-Key Solution, a one-stop solution that provides high-quality stem cell processing equipment and kits and the expert help needed to set up a stem cell lab in-clinic or in-hospital.
MIAMI, Nov. 9, 2017—Global Stem Cells Group (GSCG) and its affiliate AdiMarket now offer a new, turn-key solution for stem cell processing. The AdiMarket Turn-Key Solution is a one-stop solution that provides high-quality equipment and kits required for stem cell processing and the expert help needed to set up a stem cell processing lab in-clinic or in-hospital. It can also be designed for complex protocols such as cryopreservation, culturing, and expansion of adult stem cells derived from adipose tissue and bone marrow.
GSCG and AdiMarket provide everything needed to bring this ready-to-go cell processing expansion lab to scientists andinstitutions worldwide. Physician training courses in the field of regenerative medicine are also available to qualified physicians. These expert training courses provide hands-on, practical instruction under the guidance of trained medical experts in a highly visual, interactive, and clinical learning environment.
The AdiMarket Turn-Key Solution is a complete solution for installing highly customized, in-clinic or in-hospital turn-key laboratories to meet each facility’s individual needs.
“A well-planned, organized, and properly equipped laboratory supports critical research and favorable procedure outcomes by increasing efficiency and reducing lost time and wasted resources,” says Benito Novas, Global Stem Cells Group founder and CEO. This is vital to continuing to the discovery and implementation of new methods for treating patients.”
Admarket is GSCG’s online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals, offering all the tools and products practitioners need to facilitate in-office, in-clinic, or in-hospital stem cell procedures. From planning to building the lab, to training and consultation, Turn-Key Solution users are equipped in every way possible to walk in and begin using their fully-outfitted biotechnology lab.
To learn more about Global Stem Cells Group and the AdiMarket Turn-Key Solution, visit the GSCG website, email info@stemcellsgroup.com, or call +1305 560 533
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s aim is to be the largest recognized stem cell and regenerative medicine network in the world.
About Adimarket:
Adimarket, Inc., a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and healthcare professionals.
Adimarket was founded to provide practitioners the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting-edge treatments.
###
Cell Processing urn-key solution
- Published in Press Releases
